Pituitary and Thyroid Gland Lesions Induced by 2-Mercaptobenzimidazole (2-MBI) Inhalation in Male Fischer-344 Rats

Abstract

2-Mercaptobenzimidazole (2-MBI) is a member of the thioureylene compound family known for their potent antithyroid activity. Male Fischer-344 rats were exposed to 0.0, 3.13, 12.5, and 50.0 mg/m3 of 2-MBI via inhalation for 13 wk. Follicular cell hyperplasia occurred in the thyroid glands of rats from the 3 2-MBI treatment groups. Thyrotrophs in the pituitary glands from rats in these 3 groups were hyperplastic, and they had varying numbers of hypertrophic cells with either eosinophilic stippled cytoplasm or with eosinophilic globules within 1 or more large vacuoles that displaced the nucleus. These cells were compared by immunohistochemistry and ultrastructural examination to "thyroidectomy cells" within the anterior pituitary glands of thyroparathyroidectomized rats and were determined to be identical to them. Immunohistochemical staining for the β-chain of thyroid-stimulating hormone confirmed that the hyperplastic and hypertrophic cells were thyrotrophs. Ultrastructurally, hypertrophic cells in 2-MBI-treated rats and thyroidectomy cells in thyroparathyroidectomized rats had expanded cytoplasm containing either increased profiles of rough endoplasmic reticulum (RER) or one or more widely dilated cisternae of RER, which displaced other cellular organelles. 2-MBI appears to act comparably to other thioureylene compounds that have been shown to produce low serum concentrations of triiodothyronine and thyroxine, which results in thyrotroph hypertrophy and hyperplasia, resultant thyroid hyperplasia, and subsequent goiter.

Keywords

Thyrotroph thyroid-stimulating hormone (TSH)thyroid toxicity thioureylene

References

Akosa BT , Sleight SD , Nachreiner RF , and Aust SD (1982). Effects of purified polybrominated biphenyl congeners on the thyroid and pituitary glands in rats. J. Am. Coll. Toxicol. 1: 23-36.

Arnold DL , Krewski DR , Junkins DB , McGuire PF , Moodie CA , and Munro IC (1983). Reversibility of ethylenethiourea-induced thyroid lesions. Toxicol. AppL Pharmacol. 67: 264-273.

Baker BL (1974). Cytology of the pars distalis and pars intermedia . In: Handbook of Physiology: Endocrinology, Section (7)4 , R Creep and E Astwood (eds). American Society of Physiology, Washington, DC, pp. 59-61.

Banks WJ (1986). Applied Veterinary Histology, 2nd ed. Williams and Wilkins, Baltimore , pp. 467-472.

Chin WW , Maloof F. , and Habener JF (1981). Thyroid-stimulating hormone biosynthesis; cellular processing, assembly, and release of subunits. J. Biol. Chem . 256: 3059-3066.

Cooper DS (1984). Antithyroid drugs. N. Engl. J. Med. 311: 1353-1362.

Davidson B. , Soodak M. , Neary J. , Strout HV , Kieffer JD , Mover H. , and Maloof F. (1978). The irreversible inactivation of thyroid peroxidase by methylmercaptoimidazole, thiouracil, and propylthiouracil in vitro and its relationship to in vivo findings. Endocrinology 103: 871-882.

Engler H. , Taurog A. , and Dorris ML (1982). Preferential inhibition of thyroxine and 3,5,3'=triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase catalyzed iodination of thyroglobulin. Endocrinology 110: 190-197.

Engler H. , Taurog A. , Luthy C. , and Dorris ML (1983). Reversible and irreversible inhibition of thyroid peroxidase-catalyzed iodination by thioureylene drugs. Endocrinology 112: 86-95.

10.

Farquhar MG (1971). Processing of secretory products by cells of the anterior pituitary gland. Mem. Soc. Endocrinol. 19: 79-124.

11.

Furth J. , Moy P. , Hershman JM , and Ueda G. (1973j. Thyrotropic tumor syndrome. Arch. Pathol. 96: 217-226.

12.

Gaworski CL , Aranyi C. , Vana S. , Rajendran N. , Abdo K. , Levine BS , and Hall A. (1991). Prechronic inhalation toxicity studies of 2-mercaptobenzimidazole (2-MBI) in F344/N rats. Fund. Appl. Toxicol. 16: 161-171.

13.

Girod C. (1984). Fine structure of the pituitary pars distalis . In: Ultrastructure of Endocrine Cells and Tissues, Motta PM (ed). Martinus Nijhoff Publishers , Boston, pp. 12-28.

14.

Gurr JA , Vrontakis ME , Athanasian EA , Wagner CR , and Kourides IA (1986). Hormonal regulation ofthyrotropin alpha and beta subunit mRNAs. Horm. Metab. Res. 18: 382-385.

15.

Hayden DW , Wade GG , and Handler AH (1978). The goitrogenic effect of 4,4'-oxydianiline in rats and mice. Vet. Pathol. 15: 649-662.

16.

Hesch RD , Brabant G. , and Kohrle J. (1986). Metabolism of the hormones with respect to cytoprotection . Klin. Wochenschr. 64(suppl.7): 149-154.

17.

Horvath E. , Lloyd RV , and Kovacks K. (1990). Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells . Lab. Invest. 63: 511-520.

18.

Ingbar SH , Braverman LE (1986). Werner's The Thyroid, 5th ed. J. B. Lippincott, Philadelphia, PA, pp. 24-216.

19.

Janssen FW , Young EM , Kirkman SK , Sharma RN , and Ruelius HW (1981). Biotransformation of the immunomodulator, 3-(p-chlorophenyl)-2, 3-dihydro-3-hydroxythiazolo[3,2a]benzimidazole-2-acetic acid, and its relationship to thyroid toxicity. Toxicol. Appl. Pharmacol. 59: 355-363.

20.

Kohrle J. , Brabant G. , and Hesch RD (1987). Metabolism of the thyroid hormones. Horm. Res. 26: 58-78.

21.

Marchant B. , Lees JFH , and Alexander WD (1978). Antithyroid drugs. Pharmacol. Ther. B 3: 305-348.

22.

Metzentseva NV (1968). Benzimidazolethiol. In: Toxicology of New Chemical Substances Introduced into the Rubber and Tire Industry, ZI Israel'son (ed). Izd Meditsina, Moscow, pp. 180-184.

23.

Mori M. , Oshima K. , Fukuda H. , Kobayashi I. , and Wakabayashi K. (1984). Changes in the multiple components of rats pituitary TSH and TSH subunit following thyroidectomy. Acta Endocrinol. (Copenh.) 105: 49-56.

24.

Moriarty GC and Tobin RB (1976). An immunocytochemical study of TSH storage in rat thyroidectomy cells with and without D or L thyroxine treatment. J. Histochem. Cytochem. 24: 1140-1149.

25.

Nagasaka A. and Hidaka H. (1976). Effects of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodide peroxidase. J. Clin. Endocrinol. Metab . 43: 152-158.

26.

Pierce JG (1971). Eli Lilly Lecture: The subunits of pituitary thyrotropin-Their relationship to other glycoprotein hormones. Endocrinology 89: 1331-1344.

27.

Russfield AB (1967). Pathology of the endocrine glands, ovary and testis of rats and mice. In: Pathology of Laboratory Rats and Mice , E Cotchin and FJ Roe (eds). Blackwell Scientific Publications, Oxford, pp. 391-403.

28.

Searle CE , Lawson A. , and Hemmings AW (1950). Antithyroid substances 1. The mercaptoglyoxalines . Biochem. J. 47: 77-81.

29.

Stevens JT (1985). Effects of chemicals on the thyroid glands. In: Endocrine Toxicology, JA Thomas (ed). Raven Press, New York , pp. 135-147.

30.

Taurog A. (1976). The mechanism of action of the thioureylene antithyroid drugs. Endocrinology 98: 1031-1046.

31.

Visser TJ , Van Overmeeren E. , Fekkes D. , Docter R. , and Hennemann G. (1979). Inhibition of iodothyronine 5'-deiodinase by thioureylenes; structure-activity relationship. FEBS Lett. 103: 314-318.